The effect of dipeptidyl peptidase‐4 inhibitor on incidence and clinical course in bullous pemphigoi...
The effect of dipeptidyl peptidase‐4 inhibitor on incidence and clinical course in bullous pemphigoid patients in a tertiary medical center
About this item
Full title
Author / Creator
Publisher
China (Republic : 1949- ): John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
China (Republic : 1949- ): John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Several studies have reported an association between dipeptidyl peptidase 4 inhibitor (DPP4i), a commonly prescribed second‐line oral antihyperglycemic drug, and bullous pemphigoid (BP). However, the benefits of DPP4i withdrawal in patients with BP remain controversial. This study primarily aimed to evaluate the clinical severity of DPP4i‐associate...
Alternative Titles
Full title
The effect of dipeptidyl peptidase‐4 inhibitor on incidence and clinical course in bullous pemphigoid patients in a tertiary medical center
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5ea5f65044694fecbc777b8e688e969c
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5ea5f65044694fecbc777b8e688e969c
Other Identifiers
ISSN
1607-551X
E-ISSN
2410-8650
DOI
10.1002/kjm2.12731
